Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale VP General Counsel & Secretary sold 1,715 shares at $11.46 ($19,655)
  4. 4 Open-market sale Director sold 995 shares at $11.46 ($11,403)
  5. 4/A Open-market sale Director sold 11,933 shares at an average $11.23 ($134,035)
  6. 4 Open-market buy CEO and President bought 1,000 shares at $11.57 ($11,567)
  7. 4 Open-market sale Director sold 11,933 shares at an average $11.23 ($134,035)
  8. 4 Open-market buy CEO and President bought 1,000 shares at $11.92 ($11,916)
  9. 4 Open-market buy CEO and President bought 1,000 shares at $11.34 ($11,336)
  10. 4 Shares withheld for taxes VP General Counsel & Secretary gave up 5,910 shares (to pay taxes)
  11. 4 Open-market buy Director bought 5,000 shares at $11.92 ($59,587)
  12. 4 Open-market buy SVP, CFO & Treasurer bought 1,000 shares at $13.22 ($13,220)
  13. 4 Open-market buy Director bought 5,000 shares at $13.18 ($65,900)
  14. 4 Open-market buy Director bought 5,000 shares at $13.88 ($69,400)
  15. 4 Open-market buy Director bought 5,000 shares at $14.73 ($73,650)
  16. 4 Open-market buy Director bought 5,000 shares at $14.70 ($73,500)
  17. 4 Open-market buy Director bought 5,000 shares at $14.85 ($74,250)
  18. 4 Open-market buy Director bought 5,000 shares at $13.84 ($69,200)
  19. 4 Open-market buy Director bought 5,000 shares at $12.94 ($64,700)
  20. 4 Open-market buy Director bought 5,000 shares at $11.91 ($59,550)

Page 17 of 19 · 378 filings